Relationship between electrocardiographic left ventricular hypertrophy criteria and vascular structure and function

M A Gómez-Marcos1, J I Recio-Rodríguez2, M C Patino-Alonso3

  • 1Department of Medicine, Primary Care Research Unit, La Alamedilla Health Center, SACYL, REDIAPP, IBSAL, Salamanca, Spain, University of Salamanca, Salamanca, Spain.

Insights

Electrocardiographic criteria for left ventricular hypertrophy (LVH) in hypertensive patients showed correlations with vascular changes, but these associations were influenced by age and medication.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Vascular Biology

Background:

  • Hypertension frequently leads to left ventricular hypertrophy (LVH).
  • Assessing LVH through electrocardiography (ECG) is crucial for cardiovascular risk stratification.
  • The relationship between ECG-detected LVH and objective measures of vascular health requires further investigation.

Purpose of the Study:

  • To identify the electrocardiographic (ECG) criterion for left ventricular hypertrophy (LVH) that best correlates with vascular structure and function parameters in hypertensive patients.
  • To evaluate the impact of age, sex, and antihypertensive drug treatment on these associations.

Main Methods:

  • A cross-sectional study of 347 hypertensive patients.
  • ECG was used to assess LVH using 10 criteria, including a defined voltage-duration product (VDP) complex.
  • Vascular structure (carotid intima-media thickness - C-IMT) and function (pulse wave velocity - PWV, augmentation indices - CAIx, PAIx, arterial stiffness indices - AASI) were measured.
  • Multivariate analyses were performed to adjust for confounding factors.

Main Results:

  • LVH was detected in 29.10% of patients by at least one ECG criterion.
  • Patients with ECG-detected LVH exhibited higher values for vascular structure and function parameters.
  • Specific ECG criteria showed varying correlations with different vascular parameters (e.g., Lewis-VDP with C-IMT, Framingham-adjusted Cornell voltage with PWV/AASI, Novacode with CAIx/PAIx).
  • Associations between ECG-LVH and vascular parameters diminished after adjusting for age, sex, and antihypertensive drugs.

Conclusions:

  • The relationship between ECG-detected LVH and vascular structure/function in hypertensive patients is significantly influenced by age and antihypertensive medication.
  • The predictive value of specific ECG criteria for vascular abnormalities is modulated by these demographic and treatment factors.
  • Further research is needed to understand the complex interplay of these factors in cardiovascular risk assessment.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...